GlassScriptPhysician profile
Alissa A Roe
NPI 1356726046
$897.37
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $200 · 2023: $367 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $156.98 | 2022-2024 | Ova1 |
| Abbvie INC. | $113.71 | 2021-2024 | |
| Evofem Biosciences, INC. | $100.28 | 2021-2022 | |
| Exact Sciences Corporation | $70.97 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $62.19 | 2023 | Slynd |
| Astellas Pharma US INC | $60.45 | 2023 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $49.01 | 2024 | Airsupra, Farxiga |
| Organon LLC | $48.63 | 2022-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $34.00 | 2021-2023 | |
| Daiichi Sankyo INC. | $30.13 | 2022 | |
| Novo Nordisk INC | $29.84 | 2024 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $22.65 | 2024 | Shingrix |
| Mylan Pharmaceuticals INC. | $17.69 | 2021 | |
| Hologic Sales and Service, LLC | $17.14 | 2023 | Fluent Fluid Management System |
| Lilly USA, LLC | $16.43 | 2023 | Mounjaro |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $15.42 | 2023 | Myfembree |
| Fidia Pharma USA INC. | $13.52 | 2023 | Hymovis |
| Heron Therapeutics, INC. | $13.51 | 2023 | Zynrelef |
| Therapeuticsmd, INC. | $12.78 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alissa Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.